Related Experiment Videos
Hypoxic-ischemic encephalopathy: pathophysiology and implications for therapy
1Stanford University School of Medicine, Lucille Packard Children's Hospital, Palo Alto, CA, USA. cmeyers@stanford.edu
Insights
Hypoxic-ischemic encephalopathy (HIE) causes infant mortality and brain damage. New therapies like hypothermia show promise in reducing secondary neuronal injury following the initial insult.
Area of Science:
- Perinatal medicine
- Neuroscience
- Neonatal research
Background:
- Hypoxic-ischemic encephalopathy (HIE) poses significant risks in newborns, leading to high mortality and long-term neurological deficits.
- Neuronal damage in HIE extends beyond the initial insult, encompassing reperfusion injury and secondary damage for up to 72 hours.
- Pathological mechanisms include energy failure, membrane damage, calcium influx, cytokine release, and excitotoxicity, all promoting neuronal apoptosis.
Purpose of the Study:
- To review the pathophysiology of hypoxic-ischemic encephalopathy.
- To explore emerging therapeutic strategies for neonatal HIE.
- To highlight the potential of novel treatments in mitigating secondary neuronal injury.
Main Methods:
- Literature review of hypoxic-ischemic encephalopathy.
- Analysis of secondary neuronal damage mechanisms.
- Evaluation of therapeutic interventions for neonatal HIE.
Main Results:
- HIE results in acute and delayed neuronal death through multiple cellular pathways.
- Secondary injury mechanisms exacerbate brain damage in the hours following the initial hypoxic-ischemic event.
- Therapeutic hypothermia and oxygen-free radical inhibitors are identified as promising adjuncts.
Conclusions:
- Understanding the delayed secondary injury cascade is crucial for effective HIE management.
- Novel therapeutic approaches targeting these secondary mechanisms offer hope for improving outcomes in affected newborns.
- Cerebral or systemic hypothermia presents a promising follow-up strategy for newborns with HIE.
Abstract:
Hypoxic-ischemic encephalopathy continues to be a major problem in perinatal medicine because of the high mortality rate and neurological and intellectual impairment in the surviving infants. In addition to the acute necrotic damage that occurs in the neurons initially, reperfusion injury and secondary neuronal damage continue for 6 to 72 hours after the initial insult. Secondary cellular energy failure, membrane breakdown, cellular influx of calcium ions, elaboration of cytokines, and oxidation of excitory amino acids all contribute to enhanced apoptosis of the neurons. Newer forms of therapy including the use of oxygen-free radical inhibitors and mild to moderate cerebral or systemic hypothermia for 72 hours following the asphyxial period are promising adjuncts as follow-up approaches to the affected newborns.